Advisory Services Network, LLC Esperion Therapeutics, Inc. Transaction History

Advisory Services Network, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$0.73 - $3.08 $45 - $190	62 New	62 $0
Q1 2023 May 17, 2023	BUY	$1.46 - $7.3 $1,460 - $7,300	1,000 Added 892.86%	1,112 $1,000
Q4 2022 Feb 13, 2023	BUY	$5.09 - $8.5 $570 - $952	112 New	112 $0
Q4 2020 Feb 09, 2021	SELL	$24.2 - $35.76 $1,234 - $1,823	-51 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$31.18 - $52.71 $1,590 - $2,688	51 New	51 $2,000
Q4 2019 Feb 04, 2020	SELL	$35.4 - $59.82 $17,700 - $29,910	-500 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$40.74 - $51.41 $20,370 - $25,705	500 New	500 $22,000

208

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $160M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.